A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

NCT05702034 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

12532

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke; Ischemic Attack, Transient

Interventions

DRUG: Milvexian
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC

Collaborators

[object Object]